Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIC: Oxaliplatin with 5-FU/LV in Adjuvant Colon Cancer
NCT00275210Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 1998
- Primary completion
- Apr 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 19
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin in colon cancer (2 arms), sponsored by Sanofi. Primary endpoint: Disease-Free Survival at 5 years. Started Oct 1998; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00275210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275210.